Performance of Fentanyl Immunoassays in an ED Patient Population.

Catherine M MillsParker C DryjaElizabeth Champion-LyonsCharles KepplerNikolina Babic

Published in: The journal of applied laboratory medicine (2024)

A sizable portion of drug-positive samples from our ED were positive for fentanyl, with a subset of patients testing positive for fentanyl alone. Implementation of fentanyl testing into routine toxicology panels can elucidate polysubstance abuse paradigms and capture ED patients that would go undetected in standard panels.

Keyphrases

end stage renal disease
emergency department
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
patient reported outcomes